China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026)
China Pharma Holdings' (CPHI) quarterly Prepaid Assets came in at $86965.0 in Q2 2026, up 16.16% on a YoY basis from $74869.0 in Q2 2025, and up 17.08% quarter-over-quarter from $74279.0 in Q1 2026.
Analysis
China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Prepaid Assets for 13 consecutive years, with $86965.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets rose 16.16% year-over-year to $86965.0; the trailing twelve-month figure through Jun 2026 stood at $86965.0 (up 16.16% YoY), and the FY2025 full-year result was $82368.0, up 1.28% from the prior year.
- Prepaid Assets advanced to $86965.0 in Q2 2026 per CPHI's latest filing, from $74279.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $268498.0 in Q3 2023 and bottomed at $71788.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $106550.8 across 5 years, with a median of $87117.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 207.67% in 2023, then sank 59.57% in 2025.
- Over 5 years, Prepaid Assets stood at $77697.0 in 2022, then soared by 41.91% to $110258.0 in 2023, then declined by 26.24% to $81328.0 in 2024, then gained by 1.28% to $82368.0 in 2025, then climbed by 5.58% to $86965.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $86965.0, $74279.0, and $82368.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86,965.00 |
| Mar 31, 2026 | 74,279.00 |
| Dec 31, 2025 | 82,368.00 |
| Sep 30, 2025 | 75,627.00 |
| Jun 30, 2025 | 74,869.00 |
| Mar 31, 2025 | 82,469.00 |
| Dec 31, 2024 | 81,328.00 |
| Sep 30, 2024 | 114,202.00 |
| Jun 30, 2024 | 115,610.00 |
| Mar 31, 2024 | 203,999.00 |
| Dec 31, 2023 | 110,258.00 |
| Sep 30, 2023 | 268,498.00 |
| Jun 30, 2023 | 117,979.00 |
| Mar 31, 2023 | 102,774.00 |
| Dec 31, 2022 | 77,697.00 |
| Sep 30, 2022 | 87,269.00 |
| Jun 30, 2022 | 89,935.00 |
| Mar 31, 2022 | 71,788.00 |
| Dec 31, 2021 | 58,792.00 |
| Sep 30, 2021 | 72,805.00 |